keyword
https://read.qxmd.com/read/38709287/surgical-resection-of-advanced-intrathoracic-tumors-through-a-combination-of-the-hemiclamshell-and-transmanubrial-approaches
#1
JOURNAL ARTICLE
Yudai Miyashita, Eriko Fukui, Hiroto Ishida, Toru Kimura, Takashi Kanou, Naoko Ose, Soichiro Funaki, Yasushi Shintani
PURPOSE: The hemiclamshell (HCS) approach provides a comprehensive view of the anterior mediastinum, whereas the transmanubrial osteomuscular sparing approach (TMA) allows sufficient exposure of the cervico-thoracic transition. We assessed the effectiveness and the outcomes of the combined HCS plus TMA approach to resect thoracic malignant tumors. METHODS: We reviewed five patients with thoracic malignant tumors invading the thoracic outlet who underwent surgery using an HCS and TMA approach between 2018 and 2021...
May 6, 2024: Surgery Today
https://read.qxmd.com/read/38697554/absence-of-atm-leads-to-altered-nk-cell-function-in-mice
#2
JOURNAL ARTICLE
Daniela Angela Covino, Maria Giovanna Desimio, Alessandro Giovinazzo, Bruna Sabino Pinho de Oliveira, Matilde Merolle, Daniela Marazziti, Manuela Pellegrini, Margherita Doria
Ataxia-telangiectasia (A-T) is a rare disorder caused by genetic defects of A-T mutated (ATM) kinase, a key regulator of stress response, and characterized by neurodegeneration, immunodeficiency, and high incidence of cancer. Here we investigated NK cells in a mouse model of A-T (Atm-/- ) showing that they are strongly impaired at killing tumor cells due to a block of early signaling events. On the other hand, in Atm-/- littermates with thymic lymphoma NK cell cytotoxicity is enhanced as compared with ATM-proficient mice, possibly via tumor-produced TNF-α...
April 30, 2024: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/38696710/patient-with-mediastinal-carcinoma-of-unknown-primary-with-ret-fusion-achieves-durable-response-with-ret-inhibition
#3
JOURNAL ARTICLE
Adam Barsouk, Omar Elghawy, Sara Stone, Aditi Singh
Selective RET inhibitors have shown promise in thyroid cancer (TC) and nonsmall cell lung cancer (NSCLC) harboring RET fusions on next-generation sequencing (NGS), although rarity of the rearrangement has led to limited data for certain tumor types, such as carcinoma of unknown primary. We present a 65-year-old female with no history of malignancy, smoking or radiation exposure, who was found to have an anterior mediastinum malignancy of unknown primary, with metastases to supraclavicular lymph nodes. Core biopsy of the mediastinum revealed poorly differentiated carcinoma, while a biopsy of the thyroid revealed atypia of indeterminate significance (Bethesda III)...
April 29, 2024: Anti-cancer Drugs
https://read.qxmd.com/read/38693424/long-non-coding-rna-loxl1-as1-a-potential-biomarker-and-therapeutic-target-in-human-malignant-tumors
#4
REVIEW
Xiao-Ping Fu, Chun-Yan Ji, Wen-Qian Tang, Ting-Ting Yu, Lei Luo
Long non-coding RNAs (lncRNAs) are transcripts that contain more than 200 nucleotides. Despite their inability to code proteins, multiple studies have identified their important role in human cancer through different mechanisms. LncRNA lysyl oxidase like 1 antisense RNA 1 (LOXL1-AS1), a newly discovered lncRNA located on human chromosome 15q24.1, has recently been shown to be involved in the occurrence and progression of various malignancies, such as colorectal cancer, gastric cancer, hepatocellular carcinoma, prostate cancer, non-small cell lung cancer, ovarian cancer, cervical cancer, breast cancer, glioma, thymic carcinoma, pancreatic carcinoma...
May 2, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38672067/molecular-pathology-of-thyroid-tumors-essential-points-to-comprehend-regarding-the-latest-who-classification
#5
REVIEW
Tomohiro Chiba
In 2022, the new WHO Classification of Endocrine and Neuroendocrine Tumors, Fifth Edition (beta version) (WHO 5th), was published. Large-scale genomic analyses such as The Cancer Genome Atlas (TCGA) have revealed the importance of understanding the molecular genetics of thyroid tumors. Consequently, the WHO 5th was fundamentally revised, resulting in a systematic classification based on the cell of origin of tumors and their clinical risk. This paper outlines the following critical points of the WHO 5th. 1...
March 22, 2024: Biomedicines
https://read.qxmd.com/read/38629065/autoimmunity-in-thymic-epithelial-tumors-a-not-yet-clarified-pathologic-paradigm-associated-with-several-unmet-clinical-needs
#6
REVIEW
Matteo Perrino, Emanuele Voulaz, Simone Balin, Gerardo Cazzato, Elena Fontana, Sara Franzese, Martina Defendi, Fabio De Vincenzo, Nadia Cordua, Roberto Tamma, Federica Borea, Marta Aliprandi, Marco Airoldi, Luigi Giovanni Cecchi, Roberta Fazio, Marco Alloisio, Giuseppe Marulli, Armando Santoro, Luca Di Tommaso, Giuseppe Ingravallo, Laura Russo, Giorgio Da Rin, Anna Villa, Silvia Della Bella, Paolo Andrea Zucali, Domenico Mavilio
Thymic epithelial tumors (TETs) are rare mediastinal cancers originating from the thymus, classified in two main histotypes: thymoma and thymic carcinoma (TC). TETs affect a primary lymphoid organ playing a critical role in keeping T-cell homeostasis and ensuring an adequate immunological tolerance against "self". In particular, thymomas and not TC are frequently associated with autoimmune diseases (ADs), with Myasthenia Gravis being the most common AD present in 30% of patients with thymoma. This comorbidity, in addition to negatively affecting the quality and duration of patients' life, reduces the spectrum of the available therapeutic options...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38626709/long-term-follow-up-and-exploratory-analysis-of-lenvatinib-in-patients-with-metastatic-or-recurrent-thymic-carcinoma-results-from-the-multicenter-phase-2-remora-trial
#7
JOURNAL ARTICLE
Seiji Niho, Jun Sato, Miyako Satouchi, Shoichi Itoh, Yusuke Okuma, Hidenori Mizugaki, Haruyasu Murakami, Yasuhito Fujisaka, Toshiyuki Kozuki, Kenichi Nakamura, Ryunosuke Machida, Yuichiro Ohe, Toshiyuki Tamai, Hiroki Ikezawa, Noboru Yamamoto
OBJECTIVES: The main objective of this report was to detail the long-term follow-up data from the REMORA study, which investigated the safety and efficacy of lenvatinib in patients with thymic carcinoma. In addition, an exploratory analysis of the association between relative dose intensity (RDI) and the efficacy of lenvatinib is presented. MATERIALS AND METHODS: The single-arm, open-label, phase 2 REMORA study was conducted at eight Japanese institutions. Forty-two patients received oral lenvatinib 24 mg once daily in 4-week cycles until the occurrence of intolerable adverse events or disease progression...
March 30, 2024: Lung Cancer: Journal of the International Association for the Study of Lung Cancer
https://read.qxmd.com/read/38618298/thymic-adenocarcinoma-with-metastasis-to-the-left-orbit-a-case-report
#8
Renata Quevedo, Sebastian Garcia, John C Cravero, Andrew Horton, Blaine Berger, Roberto I Aguirre
We present the case of a 57-year-old female who initially presented with a chief complaint of left-sided orbital headaches and associated left eyelid swelling. Initial imaging work-up with CT head/orbit revealed soft tissue enhancement of the left orbital roof, concerning for neoplastic process (primary lymphoma versus extracranial primary tumor versus metastatic tumor). Further imaging studies with CT chest/abdomen/pelvis revealed an anterior mediastinal mass, concerning for possible thymoma versus lymphoma...
March 2024: Curēus
https://read.qxmd.com/read/38611047/immunotherapy-for-thymomas-and-thymic-carcinomas-current-status-and-future-directions
#9
REVIEW
Arun Rajan, Alisa K Sivapiromrat, Meredith J McAdams
Thymic epithelial tumors are a histologically diverse group of cancers arising from the epithelial compartment of the thymus. These tumors are characterized by a low tumor mutation burden, a lack of actionable genomic changes, and, especially with thymomas, defects in immune tolerance. Surgery is the mainstay of the management of resectable disease, whereas advanced, unresectable tumors are treated with platinum-based chemotherapy. Disease recurrence can occur months to years after frontline treatment. Although several options are available for conventional treatment of recurrent thymic tumors, response rates are generally low, and treatment-related toxicity can affect quality of life...
March 30, 2024: Cancers
https://read.qxmd.com/read/38608177/chemotherapy-versus-chemotherapy-plus-immune-checkpoint-inhibitors-for-the-first-line-treatment-of-unresectable-thymic-carcinoma-a-multicenter-retrospective-study
#10
JOURNAL ARTICLE
Baishen Zhang, Yao Liu, Zhiting Chen, Jing Chen, Hui Yu, Meichen Li, Shudong Ma, Chao Cheng, Likun Chen
Thymic carcinoma (TC) is a rare malignant tumor with a poor prognosis, and there is currently limited data on the use of immunotherapy in patients with unresectable TC. In this study, data of patients with unresectable TC diagnosed from January 2017 were retrospectively collected from multiple centers. Treatment response, progression-free survival (PFS), overall survival (OS), survival-independent prognostic factor, and adverse events (AEs) were further analyzed. As a result, a total of 93 patients with unresectable TC were enrolled, of which 54 received first-line chemotherapy, and 39 received chemotherapy plus immune checkpoint inhibitors (ICIs)...
April 12, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38600507/first-in-human-study-of-gfh018-a-small-molecule-inhibitor-of-transforming-growth-factor-%C3%AE-receptor-i-inhibitor-in-patients-with-advanced-solid-tumors
#11
JOURNAL ARTICLE
Ye Guo, Zishu Wang, Huan Zhou, Hongming Pan, Weidong Han, Yanhong Deng, Qun Li, Junli Xue, Xiaoxiao Ge, Shuang Wang, Jing Wang, Yue Zhang, Congqiao Zhao, Huaqiang Zhu, Yu Wang, Haige Shen, Dong Liu, Jin Li
BACKGROUND: Transforming growth factor-β (TGF-β) is a cytokine with multiple functions, including cell growth regulation, extracellular matrix production, angiogenesis homeostasis adjustment and et al. TGF-β pathway activation promotes tumor metastasis/progression and mediates epithelial-mesenchymal transmission suppressing immunosurveillance in advanced tumors. GFH018, a small molecule inhibitor blocking TGF-β signal transduction, inhibits the progression and/or metastasis of advanced cancers...
April 10, 2024: BMC Cancer
https://read.qxmd.com/read/38589618/tcf1-lef1-co-expression-identifies-a-multipotent-progenitor-cell-t-h-2-mpp-across-human-allergic-diseases
#12
JOURNAL ARTICLE
Radomir Kratchmarov, Sarah Djeddi, Garrett Dunlap, Wenqin He, Xiaojiong Jia, Caitlin M Burk, Tessa Ryan, Alanna McGill, Jessica R Allegretti, Raghu P Kataru, Babak J Mehrara, Erin M Taylor, Shailesh Agarwal, Neil Bhattacharyya, Regan W Bergmark, Alice Z Maxfield, Stella Lee, Rachel Roditi, Daniel F Dwyer, Joshua A Boyce, Kathleen M Buchheit, Tanya M Laidlaw, Wayne G Shreffler, Deepak A Rao, Maria Gutierrez-Arcelus, Patrick J Brennan
Repetitive exposure to antigen in chronic infection and cancer drives T cell exhaustion, limiting adaptive immunity. In contrast, aberrant, sustained T cell responses can persist over decades in human allergic disease. To understand these divergent outcomes, we employed bioinformatic, immunophenotyping and functional approaches with human diseased tissues, identifying an abundant population of type 2 helper T (TH 2) cells with co-expression of TCF7 and LEF1, and features of chronic activation. These cells, which we termed TH 2-multipotent progenitors (TH 2-MPP) could self-renew and differentiate into cytokine-producing effector cells, regulatory T (Treg ) cells and follicular helper T (TFH ) cells...
April 8, 2024: Nature Immunology
https://read.qxmd.com/read/38576812/multilocular-thymic-cysts-can-be-easily-misdiagnosed-as-malignant-tumor-on-computer-tomography-a-case-report
#13
Jun Sun, Qing-Ning Yang, Yi Guo, Ping Zeng, Long-Yan Ma, Ling-Wen Kong, Bo-Ying Zhao, Chuan-Ming Li
BACKGROUND: Multilocular thymic cyst (MTC) is a rare mediastinal lesion which is considered to occur in the process of acquired inflammation. It is usually characterized by well-defined cystic density and is filled with transparent liquid. CASE SUMMARY: We report on a 39-year-old male with a cystic-solid mass in the anterior mediastinum. Computer tomography (CT) imaging showed that the mass was irregular with unclear boundaries. After injection of contrast agent, there was a slight enhancement of stripes and nodules...
March 16, 2024: World Journal of Clinical Cases
https://read.qxmd.com/read/38572512/rev1-overexpression-accelerates-n-methyl-n-nitrosourea-mnu-induced-thymic-lymphoma-by-increasing-mutagenesis
#14
JOURNAL ARTICLE
Megumi Sasatani, Yang Xi, Kazuhiro Daino, Atsuko Ishikawa, Yuji Masuda, Junko Kajimura, Jinlian Piao, Elena Karamfilova Zaharieva, Hiroaki Honda, Guanyu Zhou, Kanya Hamasaki, Yoichiro Kusunoki, Tsutomu Shimura, Shizuko Kakinuma, Yoshiya Shimada, Kazutaka Doi, Tomoko Ishikawa-Fujiwara, Yusuke Sotomaru, Kenji Kamiya
Rev1 has two important functions in the translesion synthesis pathway, including dCMP transferase activity, and acts as a scaffolding protein for other polymerases involved in translesion synthesis. However, the role of Rev1 in mutagenesis and tumorigenesis in vivo remains unclear. We previously generated Rev1-overexpressing (Rev1-Tg) mice and reported that they exhibited a significantly increased incidence of intestinal adenoma and thymic lymphoma (TL) after N-methyl-N-nitrosourea (MNU) treatment. In this study, we investigated mutagenesis of MNU-induced TL tumorigenesis in wild-type (WT) and Rev1-Tg mice using diverse approaches, including whole-exome sequencing (WES)...
April 4, 2024: Cancer Science
https://read.qxmd.com/read/38566968/development-of-a-novel-humanized-anti-tslp-monoclonal-antibody-hz-1127-with-anti-allergic-diseases-and-cancer-potential
#15
JOURNAL ARTICLE
Xiaolei Liu, Jianzhong Han, Qian Wang, Peng Wang, Li Li, Kehe Du, Fengchao Jiang, Pei Zhang, Hongjun Liu, Jian Huang
Thymic stromal lymphopoietin (TSLP) is a member of the IL-2 cytokine family and has been widely recognized as a master regulator of type 2 inflammatory responses at barrier surfaces. Recent studies found dysregulation of the TSLP-TSLP receptor (TSLPR) pathway is associated with the pathogenesis of not only allergic diseases but also a wide variety of cancers including both solid tumors and hematological tumors. Thus, the blockade of TSLP represents an attractive therapeutic strategy for allergic diseases and cancer...
April 2024: Antibody Therapeutics
https://read.qxmd.com/read/38560659/clinical-spectrum-and-evolution-of-immune-checkpoint-inhibitors-toxicities-over-a-decade-a-worldwide-perspective
#16
JOURNAL ARTICLE
Paul Gougis, Floriane Jochum, Baptiste Abbar, Elise Dumas, Kevin Bihan, Bénédicte Lebrun-Vignes, Javid Moslehi, Jean-Philippe Spano, Enora Laas, Judicael Hotton, Fabien Reyal, Anne-Sophie Hamy, Joe-Elie Salem
BACKGROUND: Immune-checkpoint inhibitors (ICI) have revolutionized cancer treatment by harnessing the immune system but ICI can induce life-threatening immune-related adverse events (irAE) affecting every organ. METHODS: We extracted irAE from VigiBase, the international pharmacovigilance database, first reported in 2008 until 01/2023 to characterize irAE reporting trends, clinical features, risk factors and outcomes. FINDINGS: We distinguished 25 types of irAE (n = 50,347cases, single irAE/case in 84...
April 2024: EClinicalMedicine
https://read.qxmd.com/read/38558927/thymic-nk-cells-and-their-potential-in-cancer-immunotherapy
#17
REVIEW
Caitlyn Forbes, Stefan Nierkens, Annelisa M Cornel
Natural killer (NK)-cells are innate immune cells with potent anti-tumor capacity, capable of recognizing target cells without prior exposure. For this reason, NK-cells are recognized as a useful source of cell therapy. Although most NK-cells are derived from the bone marrow (BM), a separate developmental pathway in the thymus also exists, producing so-called thymic NK-cells. Unlike conventional NK-cells, thymic NK (tNK)-cells have a combined capacity for cytokine production and a natural ability to kill tumor cells in the presence of NK-cell receptor stimulatory ligands...
2024: ImmunoTargets and Therapy
https://read.qxmd.com/read/38557942/relevance-of-thymic-stromal-lymphopoietin-on-the-pathogenesis-of-glioblastoma-role-of-the-neutrophil
#18
JOURNAL ARTICLE
Alejandra Infante Cruz, Juan Valentin Coronel, Paula Saibene Vélez, Federico Remes Lenicov, Juan Iturrizaga, Martín Abelleyro, Micaela Rosato, Carolina Maiumi Shiromizu, Marianela Candolfi, Mónica Vermeulen, Carolina Jancic, Ezequiel Yasuda, Silvia Berner, Marcela Solange Villaverde, Gabriela Verónica Salamone
Glioblastoma multiforme (GBM) is the most predominant and malignant primary brain tumor in adults. Thymic stromal lymphopoietin (TSLP), a cytokine primarily generated by activated epithelial cells, has recently garnered attention in cancer research. This study was aimed to elucidate the significance of TSLP in GBM cells and its interplay with the immune system, particularly focused on granulocyte neutrophils. Our results demonstrate that the tumor produces TSLP when stimulated with epidermal growth factor (EGF) in both the U251 cell line and the GBM biopsy (GBM-b)...
April 1, 2024: Cellular and Molecular Neurobiology
https://read.qxmd.com/read/38551395/pd-1-limits-il-2-production-and-thymic-regulatory-t-cell-development
#19
JOURNAL ARTICLE
Breanna Caruso, Benjamin R Weeder, Reid F Thompson, Amy E Moran
Inhibitory proteins, such as programmed cell death protein 1 (PD-1), have been studied extensively in peripheral T cell responses to foreign Ags, self-Ags, and neoantigens. Notably, these proteins are first expressed during T cell development in the thymus. Reports suggest that PD-1 limits regulatory T cell (Treg) development, but the mechanism by which PD-1 exerts this function remains unknown. The present study expands the evaluation of murine PD-1 and its ligands in the thymus, demonstrating that some of the highest expressers of PD-1 and programmed death-ligand 1 are agonist selected cells...
March 1, 2024: ImmunoHorizons
https://read.qxmd.com/read/38484307/the-role-of-18-f-fdg-pet-ct-in-the-characterization-of-thymic-epithelial-tumors-at-initial-stage
#20
JOURNAL ARTICLE
Caner Civan, Zeynep Gozde Ozkan, Berker Ozkan, Emine Goknur Isik, Eren Erdogdu, Duygu Has Simsek, Salih Duman, Yasemin Sanli, Murat Kara, Serkan Kuyumcu, Alper Toker
Purpose: The aim of this study was to evaluate the potential role of [18 F]FDG positron emission tomography/computed tomography (PET/CT) in the characterization of thymic epithelial tumors (TETs). Materials and Methods: A total of 73 patients who underwent preoperative [18 F]FDG PET/CT were included in this study. Visual total score (VTS), maximum standard uptake values (SUVmax), metabolic tumor volume (MTV), total lesion glycolysis (TLG), and heterogeneity index (HI) parameters were analyzed to investigate the prediction of histopathologic grade and advanced stage...
March 14, 2024: Cancer Biotherapy & Radiopharmaceuticals
keyword
keyword
50102
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.